Medical & Bio Strategy Weekly Report– category –

Vol. 49 | 2026.07.06 — 07.12 | Market Mood: 80 / 100 — Optimistic Precision Medicine stands at a pivotal frontier. This report dissects the convergence of advanced cell therapies, AI-driven drug discovery, and real-time biosensing, redef...

Vol. 49 | 2026.06.29 — 07.05 | Market Mood: 78 / 100 — Optimistic Our intelligence report, "AI-Driven Biopharma Acceleration," explores how AI, advanced manufacturing, and precision diagnostics are reshaping Medical &...

Vol. 48 | 2026.06.22 — 06.28 | Market Mood: 78 / 100 — Optimistic Our report details how AI & Advanced Biologics reshape medical innovation by 2026, accelerating patient access and R&D pipelines. Key breakthroughs: AI...

Vol. 48 | 2026.06.15 — 06.21 | Market Mood: 70 / 100 — Optimistic The Medical & Bio domain is rapidly transforming, driven by advanced therapies, AI-driven discovery, and pervasive biosensing. Pharma 4.0 achieves 75% ...

Vol. 48 | 2026.05.25 — 05.31 | Market Mood: 80 / 100 — Positive Momentum Our latest Medical & Bio report details a pivotal biotech convergence, accelerating digital health. AI and automation are driving 2x faster drug...

Vol. 48 | 2026.05.25 — 05.31 | Market Mood: 80 / 100 — Positive Momentum This week's B2B intelligence report unpacks the profound convergence reshaping medical innovation. AI-driven drug discovery, advanced cell and g...